Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Other Accumulated Expenses (2016 - 2017)

Wave Life Sciences filings provide 4 years of Other Accumulated Expenses readings, the most recent being $156000.0 for Q4 2017.

  • On a quarterly basis, Other Accumulated Expenses fell 83.54% to $156000.0 in Q4 2017 year-over-year; TTM through Dec 2017 was $156000.0, a 83.54% decrease, with the full-year FY2017 number at $156000.0, down 83.54% from a year prior.
  • Other Accumulated Expenses hit $156000.0 in Q4 2017 for Wave Life Sciences, down from $948000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $948000.0 in Q4 2016 to a low of $156000.0 in Q4 2017.
  • Median Other Accumulated Expenses over the past 4 years was $353000.0 (2015), compared with a mean of $408000.0.
  • Biggest five-year swings in Other Accumulated Expenses: surged 168.56% in 2016 and later crashed 83.54% in 2017.
  • Wave Life Sciences' Other Accumulated Expenses stood at $177000.0 in 2014, then soared by 99.44% to $353000.0 in 2015, then surged by 168.56% to $948000.0 in 2016, then crashed by 83.54% to $156000.0 in 2017.
  • The last three reported values for Other Accumulated Expenses were $156000.0 (Q4 2017), $948000.0 (Q4 2016), and $353000.0 (Q4 2015) per Business Quant data.